Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study

OBJECTIVE: Tamoxifen is an estrogen receptor antagonist used to prevent recurrence of breast cancer, which may provoke depression and anxiety and increase follicle-stimulating hormone (FSH) to patients. We compared anxiety and depression symptoms and FSH levels who received conventional tamoxifen al...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Jung-Yoon, Yi, Hawoo, Fava, Maurizio, Mischoulon, David, Kim, Kiwon, Yoon, Sechang, Jeon, Hong Jin, Lee, Jeong Eon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561408/
https://www.ncbi.nlm.nih.gov/pubmed/28845177
http://dx.doi.org/10.4306/pi.2017.14.4.491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561408/
https://www.ncbi.nlm.nih.gov/pubmed/28845177
http://dx.doi.org/10.4306/pi.2017.14.4.491

Ejemplares similares